Liquan Xue

3.3k citations
26 papers · 1.9k indexed · h-index 17
Topics
NF-κB Signaling Pathways (9 papers)Immune Cell Function and Interaction (7 papers)Immune Response and Inflammation (7 papers)

In The Last Decade

Liquan Xue

26 papers receiving 1.9k citations

Peers

Liquan Xue
Comparison fields: 5 of 95
  • Molecular Biology 758
  • Immunology 756
  • Oncology 543
  • Cancer Research 478
  • Pathology and Forensic Medicine 460
Replace Michał Marzec with:
Michał Marzec United States
Timothy Back United States
Valeria Masciullo Italy
Mengkun Zhang United States
Hovav Nechushtan Israel
Katja Pokrovskaja Tamm Sweden
Daniel J. Murphy United Kingdom
Erik A. Nelson United States
Barry Ripley Japan
Miriam Erlacher Germany
Liquan Xue relative to Michał Marzec United States Michał Marzec's profile →
Citations per field
00.5×1.5×2.0×
Michał Marzec · 1×
Citations per year

Countries citing papers authored by Liquan Xue

Since Specialization
Citations

This map shows the geographic impact of Liquan Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liquan Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liquan Xue more than expected).

Fields of papers citing papers by Liquan Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liquan Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liquan Xue. The network helps show where Liquan Xue may publish in the future.

Co-authorship network of co-authors of Liquan Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Liquan Xue. A scholar is included among the top collaborators of Liquan Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liquan Xue. Liquan Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 174
3 5
4 1
5 48
6 76
7 80
8 183
9 46
10 49
11 13
12 24
13 272
14 80
15 36
16 17
17 220
18 92
19 303
20 8

About Liquan Xue

Liquan Xue is a scholar working on Immunology, Cancer Research and Immunology and Allergy, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (9 papers), Immune Cell Function and Interaction (7 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Immunology (756 citations), Cancer Research (478 citations) and Pathology and Forensic Medicine (460 citations). Liquan Xue has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Stephan W. Morris, Renren Wen, Xiaoli Cui, Demin Wang, Qin Jiang, Carlos J. Orihuela, Elaine Tuomanen, Tomasz Skórski, Mirosław Majewski and Mariusz A. Wasik. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026